TY - JOUR
T1 - E-Cigarette Use Patterns and High-Risk Behaviors in Pregnancy
T2 - Behavioral Risk Factor Surveillance System, 2016–2018
AU - Obisesan, Olufunmilayo H.
AU - Osei, Albert D.
AU - Uddin, S. M.Iftekhar
AU - Dzaye, Omar
AU - Cainzos-Achirica, Miguel
AU - Mirbolouk, Mohammadhassan
AU - Orimoloye, Olusola A.
AU - Sharma, Garima
AU - Al Rifai, Mahmoud
AU - Stokes, Andrew
AU - Bhatnagar, Aruni
AU - El Shahawy, Omar
AU - Benjamin, Emelia J.
AU - DeFilippis, Andrew P.
AU - Blaha, Michael J.
N1 - Publisher Copyright:
© 2020 American Journal of Preventive Medicine
PY - 2020/8
Y1 - 2020/8
N2 - Introduction: The prevalence of e-cigarette use has increased dramatically in the last decade in the U.S. Understanding the prevalence, patterns of use, and risk factor associations of e-cigarette use in pregnant women is particularly important, as this could have potential health implications for the mother and the developing child. Methods: Using Behavioral Risk Factor Surveillance System Survey data from 2016 to 2018, adult women of reproductive age (18–49 years) who reported being pregnant (n=7,434) were studied. Self-reported current e-cigarette use was the main exposure. Other measures included combustible cigarette smoking status and high-risk behaviors (including other tobacco, marijuana, or heavy alcohol use; binge drinking; and others). All analyses were done in 2019. Results: Approximately 2.2% of pregnant women reported current e-cigarette use, of whom 0.6% reported daily use. The highest prevalence of e-cigarette use was observed in the youngest age group of pregnant women (3.2%), with 41.7% of all pregnant current e-cigarette users being aged 18–24 years. There was a marked increase in the prevalence of current use of e-cigarettes among pregnant women from 1.9% in 2016 to 3.8% in 2018. Approximately 46% of pregnant current e-cigarette users reported concomitant cigarette smoking. Compared with pregnant never e-cigarette users, pregnant current e-cigarette users had a higher prevalence of other tobacco product use, marijuana use, heavy alcohol intake, binge drinking, and other high-risk behaviors. Conclusions: These findings underscore the need to strengthen prevention and policy efforts, specifically in the vulnerable subgroup of pregnant women.
AB - Introduction: The prevalence of e-cigarette use has increased dramatically in the last decade in the U.S. Understanding the prevalence, patterns of use, and risk factor associations of e-cigarette use in pregnant women is particularly important, as this could have potential health implications for the mother and the developing child. Methods: Using Behavioral Risk Factor Surveillance System Survey data from 2016 to 2018, adult women of reproductive age (18–49 years) who reported being pregnant (n=7,434) were studied. Self-reported current e-cigarette use was the main exposure. Other measures included combustible cigarette smoking status and high-risk behaviors (including other tobacco, marijuana, or heavy alcohol use; binge drinking; and others). All analyses were done in 2019. Results: Approximately 2.2% of pregnant women reported current e-cigarette use, of whom 0.6% reported daily use. The highest prevalence of e-cigarette use was observed in the youngest age group of pregnant women (3.2%), with 41.7% of all pregnant current e-cigarette users being aged 18–24 years. There was a marked increase in the prevalence of current use of e-cigarettes among pregnant women from 1.9% in 2016 to 3.8% in 2018. Approximately 46% of pregnant current e-cigarette users reported concomitant cigarette smoking. Compared with pregnant never e-cigarette users, pregnant current e-cigarette users had a higher prevalence of other tobacco product use, marijuana use, heavy alcohol intake, binge drinking, and other high-risk behaviors. Conclusions: These findings underscore the need to strengthen prevention and policy efforts, specifically in the vulnerable subgroup of pregnant women.
UR - http://www.scopus.com/inward/record.url?scp=85084234559&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084234559&partnerID=8YFLogxK
U2 - 10.1016/j.amepre.2020.02.015
DO - 10.1016/j.amepre.2020.02.015
M3 - Article
C2 - 32362509
AN - SCOPUS:85084234559
SN - 0749-3797
VL - 59
SP - 187
EP - 195
JO - American journal of preventive medicine
JF - American journal of preventive medicine
IS - 2
ER -